Hadi Mohamad Abu Rasheed, Scientific Advisor at the Qatar Cancer Society and an Adjunct Lecturer at the University of Doha for Science and Technology, shared a post on LinkedIn:
“Contributing to a national strategy means helping translate its vision into measurable improvements for patients, healthcare professionals, and the health system.
I am pleased to share my ongoing contribution to Qatar’s National Health Strategy 2024-2030 through my involvement in the Ministry of Public Health’s National Clinical Effectiveness Program.
The National Health Strategy 2024-2030 – ‘Health for All’ – aims to build a health-focused society supported by an integrated health system centred on clinical excellence, sustainability, and innovation.
Within this national framework, the National Clinical Effectiveness Program supports the assessment and improvement of healthcare quality, safety, patient experience, and clinical outcomes. It helps examine whether clinical practices are evidence-based, cost-effective, aligned with national guidance, and translated into measurable improvements across the healthcare system.
As a member of the program’s Technical Working Group, my involvement extends across multiple interconnected areas:
- The Patient Workstream, contributing patient, caregiver, civil-society, and people-centred perspectives.
- The Research Task Group, supporting the review, validation, testing, and refinement of national clinical-effectiveness assessment tools.
- The PROMs expert-validation process, serving as a subject-matter expert and providing technical feedback on the national Patient-Reported Outcome Measures Situational Analysis Survey.
- Cross-stream work connecting patient-reported outcomes with System and Performance assessment.
One of the central messages I have sought to bring to this work is that patient-reported data are essential – but collecting PROMs and PREMs alone does not constitute meaningful patient engagement.
Patients, carers, people with lived experience, and patient organisations should be partners throughout priority-setting, co-design, implementation, monitoring, evaluation, and quality improvement. Their involvement should help shape assessment tools, patient-relevant indicators, clinical audits, interpretation of findings, and the improvement actions that follow.
This work strongly connects with my professional journey in cancer control and patient advocacy. Cancer care demonstrates clearly that clinical effectiveness cannot be understood through clinical outcomes alone. It must also consider the complete patient journey, care experience, psychosocial needs, quality of life, survivorship, and the outcomes that matter most to patients and families.
I look forward to continuing to help bridge national health priorities, clinical evidence, system performance, meaningful patient engagement, and people-centred care.”
More posts featuring Hadi Mohamad Abu Rasheed.